Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1AS----6件: 46, 53, 96, 97, 215, 271
2B-lines SE----3件: 58, 86, 215
3Calcium1件: Calcium---30件: 3, 6, 13, 15, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 256, 265, 274, 298, 299
4Calcium gluconate2件: Calcium,
Calcium gluconate		1件: D00935 --3件: 214, 215, 235
5Cardiac MRI----1件: 215
6Cellvizio 100 Series System with Confocal Miniprobes----1件: 215
7Coenzyme Q101件: Ubidecarenone1件: D01065 --12件: 2, 5, 6, 8, 10, 18, 46, 57, 113, 193, 214, 215
8Cold Cadioplegia----1件: 215
9Coronary flow reserve SE----3件: 58, 86, 215
10CPX----2件: 215, 299
11DEXMEDETOMIDINE1件: Dexmedetomidine2件: D00514 ,
D01205 		3件: ADRA2A,
ADRA2B,
ADRA2C 💬		2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬13件: 2, 4, 6, 21, 34, 46, 70, 107, 113, 212, 215, 226, 280
12Diastolic function SE----3件: 58, 86, 215
13Dobutamin1件: Dobutamine4件: D00632 ,
D03879 ,
D03880 ,
D03881 		1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 215
14Dobutamine1件: Dobutamine4件: D00632 ,
D03879 ,
D03880 ,
D03881 		1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬3件: 57, 58, 215
15Echocardiogram----2件: 19, 215
16Eplerenone1件: Eplerenone1件: D01115 1件: NR3C2 💬1件: Aldosterone-regulated sodium reabsorption 💬4件: 75, 113, 210, 215
17Fentanyl1件: Fentanyl2件: D00320 ,
D01399 		1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬4件: 46, 70, 215, 231
18Fentanyl (High Dose)1件: Fentanyl2件: D00320 ,
D01399 		1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬1件: 215
19Fentanyl (Low Dose)1件: Fentanyl2件: D00320 ,
D01399 		1件: OPRM1 💬3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬1件: 215
20Fentanyl (Low Dose) + Dexmedetomidine2件: Dexmedetomidine,
Fentanyl		4件: D00320 ,
D00514 ,
D01205 ,
D01399 		4件: ADRA2A,
ADRA2B,
ADRA2C,
OPRM1 💬		4件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 215
21Fluorescite----1件: 215
22Gradient----4件: 58, 86, 149, 215
23HTK cardioplegia----1件: 215
24KETAMINE1件: Ketamine2件: D00711 ,
D08098 		5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬		20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬6件: 6, 13, 70, 113, 156, 215
25Left ventricular contractile reserve SE----3件: 58, 86, 215
26Left ventricular outflow tract gradient SE----3件: 58, 86, 215
27Losartan1件: Losartan2件: D00357 ,
D08146 		1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299
28LOSARTAN POTASSIUM2件: Losartan,
Potassium		3件: D00357 ,
D08146 ,
D08403 		1件: AGTR1 💬16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬5件: 36, 98, 167, 179, 215
29Mitral regurgitation SE----3件: 58, 86, 215
30Other: dobutamine1件: Dobutamine4件: D00632 ,
D03879 ,
D03880 ,
D03881 		1件: ADRB1 💬11件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 215
31Other: N-thymidine1件: Thymidine---1件: 215
32Other: Specimen Collection----1件: 215
33Other: Transthoracic echocardiography at rest, during PLR, HG and CPX (including blood gas analysis in both groups). Additionally Fallot patients will undergo routine blood testings.----1件: 215
34Other: Urine Collection----1件: 215
35Physical Exam----1件: 215
36Potassium1件: Potassium1件: D08403 --12件: 36, 46, 66, 67, 88, 94, 98, 115, 167, 179, 215, 235
37Propranolol1件: Propranolol2件: D00483 ,
D08443 		3件: ADRB1,
ADRB2,
ADRB3 💬		12件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬6件: 6, 158, 167, 215, 227, 278
38Propranolol Hydrochloride1件: Propranolol2件: D00483 ,
D08443 		3件: ADRB1,
ADRB2,
ADRB3 💬		12件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 215
39Pulmonary hemodynamics SE----3件: 58, 86, 215
40PV----3件: 13, 97, 215
41Recombinant human brain natriuretic peptide (rhBNP)----1件: 215
42Sodium citrate1件: Sodium citrate2件: D01781 ,
D05855 		--4件: 67, 214, 215, 235
43SULFUR HEXAFLUORIDE1件: Sulfur hexafluoride1件: D05962 --2件: 96, 215
44Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Injection Powder for Suspension [LUMASON]1件: Sulfur hexafluoride1件: D05962 --1件: 215
45Thymidine1件: Thymidine---1件: 215
46TOF repair with trans-annular patch VS preservation of PV----1件: 215
47Tranexamic acid1件: Tranexamic acid1件: D01136 1件: PLG 💬4件: Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬6件: 46, 70, 215, 227, 288, 299